Abiomed Inc (ABMD):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Abiomed Inc (ABMD) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7505
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abiomed Inc (Abiomed) is a provider of mechanical circulatory support devices. It develops, manufactures and markets novel technologies designed to replace or assist the pumping function in a failing heart. The company’s heart support and recovery product portfolio includes catheters for circulatory support; minimally invasive implantable cardiac assist devices; and percutaneous catheter-based devices including micro heart pumps, expandable catheter pumps and axial flow pumps. Abiomed also offers automated controllers, designed to control and monitor the catheter performance and display real time hemodynamic and catheter position information. It has manufacturing facilities in Danvers, Massachusetts; and Aachen, Germany. The company sells its products through direct sales and distributors in the Americas, Europe, Asia and the Middle East. Abiomed is headquartered in Danvers, Massachusetts, the US.

Abiomed Inc (ABMD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Abiomed Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Abiomed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Abiomed Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Abiomed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Abiomed Inc, Medical Equipment, Deal Details 11
Venture Financing 11
Reprieve Cardiovascular Raises USD7 Million in Venture Financing 11
Magenta Medical Raises USD15 Million in Series B Financing 12
ALung Technologies Raises Funds through Series C Financing 13
Partnerships 15
Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology 15
Acquisition 16
Abiomed Acquires ECP from Syscore for USD13 Million 16
Abiomed Inc – Key Competitors 17
Abiomed Inc – Key Employees 18
Abiomed Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Strategy And Business Planning 20
Mar 30, 2017: Abiomed Marks Grand Opening of Newly-Expanded Headquarters in Danvers, Massachusetts 20
Financial Announcements 21
Jul 26, 2018: Abiomed announces Q1 FY 2019 record revenue of $180 million, Up 36% over prior year 21
May 03, 2018: Abiomed Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year Revenue of $594 Million, Up 33%, Over Prior Year 22
Feb 01, 2018: Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year 23
Jan 08, 2018: Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154M, Up 34% Over Prior Year 24
Oct 26, 2017: Abiomed Announces Q2 FY 2018 Revenue of $132.8 Million, Up 29% and Record U.S. Patient Utilization, Up 33% 25
Jul 27, 2017: Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year 26
May 04, 2017: Abiomed Announces Q4 FY 2017 Revenue of $124.7 Million, Up 33% Over Prior Year and Total Year Revenue of $445.3 Million, Up 35% Over Prior Year 28
Jan 26, 2017: Abiomed Announces Q3 FY 2017 Revenue of $114.7 Million, Up 34% Over Prior Year 29
Jan 09, 2017: Abiomed Announces Preliminary Q3 FY 2017 Revenue of $114.7 Million, Up 34% Over Prior Year 30
Corporate Communications 31
Mar 30, 2018: Abiomed to Appoint New Chief Financial Officer Todd A. Trapp 31
Aug 28, 2017: Abiomed Announces Resignation of Chief Financial Officer and Welcomes Back Former Chief Financial Officer as Consultant 32
Product News 33
Sep 24, 2018: Data presented at TCT 2018 shows use of Impella and best practices increases cardiogenic shock survival 33
Mar 05, 2018: Abiomed Showcases Impella Technology that Enables Heart Recovery at ACC with 25 Presentations 34
Oct 19, 2017: Abiomed’s Impella Technology that Enables Heart Recovery Showcased at TCT 2017 With More Than 30 Presentations 35
Jun 09, 2017: Heart Recovery Patients Visit Capitol Hill to Advocate for Lifesaving Cardiovascular Technology 36
Mar 19, 2017: First-Ever Presentation on Abiomed’s Impella Quality Assurance Program at the 2017 American College of Cardiology Scientific Session 37
Mar 16, 2017: Abiomed’s Impella Technology Showcased at 2017 American College of Cardiology Scientific Session With More Than 10 Presentations 39
Other Significant Developments 41
Feb 13, 2018: Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women’s Initiative for Heart Recovery 41
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Abiomed Inc, Medical Equipment, Key Facts, 2018 2
Abiomed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Abiomed Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Abiomed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Abiomed Inc, Deals By Market, 2012 to YTD 2018 9
Abiomed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Reprieve Cardiovascular Raises USD7 Million in Venture Financing 11
Magenta Medical Raises USD15 Million in Series B Financing 12
ALung Technologies Raises Funds through Series C Financing 13
Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology 15
Abiomed Acquires ECP from Syscore for USD13 Million 16
Abiomed Inc, Key Competitors 17
Abiomed Inc, Key Employees 18
Abiomed Inc, Subsidiaries 19

List of Figures
Abiomed Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Abiomed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Abiomed Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Abiomed Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Abiomed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Abiomed Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Abiomed Inc (ABMD):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Corporation Bank:企業のM&A・事業提携・投資動向
    Corporation Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Corporation Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Liberty International Holdings Inc:企業の戦略・SWOT・財務情報
    Liberty International Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Liberty International Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Olink Proteomics AB:企業の製品パイプライン分析
    Summary Olink Proteomics AB (Olink) is a biotechnology company that offers products and services for human protein biomarker research. The company provides portfolio of products such as biomarkers, cardiovascular diseases panels, neurological disease panels, inflammation panels and oncology panels. …
  • ESSA Pharma Inc (EPI):製薬・医療:M&Aディール及び事業提携情報
    Summary Essa Pharma Inc (Essa Pharma) is a drug developer that offers oncology therapeutics. The company develops EPI-506, disrupts androgen receptor transcriptional activity through selectively blocking the N-terminal domain of the AR. It also conducts research on prostate cancer and the androgen r …
  • Shree Rama Newsprint Limited (RAMANEWS):企業の財務・戦略的SWOT分析
    Shree Rama Newsprint Limited (RAMANEWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Crown Bioscience Inc-医療機器分野:企業M&A・提携分析
    Summary Crown Bioscience Inc (Crown Bioscience) is a pharmaceutical company that provides drug discovery and development services. The company offers in vivo and in vitro research reagents. It offers preclinical contract research services in areas of oncology and metabolic disease. Crown Bioscience’ …
  • Airgain, Inc. (AIRG):企業の財務・戦略的SWOT分析
    Airgain, Inc. (AIRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Pictet & Cie Group SCA:企業の戦略・SWOT・財務情報
    Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report Summary Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Manchester United Plc:企業の戦略・SWOT・財務分析
    Manchester United Plc - Strategy, SWOT and Corporate Finance Report Summary Manchester United Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ocular Therapeutix Inc (OCUL):企業の財務・戦略的SWOT分析
    Summary Ocular Therapeutix Inc (Ocular Therapeutix), formerly I-Therapeutix Inc, is a biopharmaceutical company that discovers, develops and commercializes therapies for treating eye diseases. The company’s lead product candidate DEXTENZA is used for the treatment of post-surgical ocular inflammatio …
  • ANS Group Plc:企業の戦略的SWOT分析
    ANS Group Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Reach Subsea ASA (REACH):企業の財務・戦略的SWOT分析
    Reach Subsea ASA (REACH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Catalyst Paper Corporation (CYT):企業の戦略的SWOT分析
    Catalyst Paper Corporation (CYT) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Musgrave Group Plc:戦略・SWOT・企業財務分析
    Musgrave Group Plc - Strategy, SWOT and Corporate Finance Report Summary Musgrave Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Orbus Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Orbus Therapeutics Inc (Orbus Therapeutics) is a clinical-stage biopharmaceutical company that develops and commercializes drugs for the treatment of anaplastic astrocytoma, a rare kind of cancer afflicting the central nervous system. Eflornithine, a cytostatic agent, indicated for the treat …
  • Savara Inc (SVRA):医療機器:M&Aディール及び事業提携情報
    Summary Savara Inc (Savara) formerly Mast Therapeutics Inc is a clinical stage biopharmaceutical company, which develops therapies for the treatment of rare respiratory diseases, including cystic fibrosis (CF), and pulmonary alveolar proteinosis (PAP). The company’s lead product candidates include M …
  • MabVax Therapeutics Holdings Inc (MBVX):製薬・医療:M&Aディール及び事業提携情報
    Summary MabVax Therapeutics Holdings Inc (MabVax Therapeutics) formerly known as Telik, Inc. is a clinical-stage biotechnology company that focuses on development of pipeline of human monoclonal antibody products for diagnosis and treatment of cancer. The company's research and development activitie …
  • Vietnam National Oil and Gas Group:石油・ガス:M&Aディール及び事業提携情報
    Summary Vietnam National Oil and Gas Group (Petrovietnam) is an oil and gas exploration and production company. The company conducts petroleum activities and signs petroleum contracts with organizations and individuals. Its services include oil and natural gas exploration and production, petroleum a …
  • Fujicco Co Ltd:企業の戦略・SWOT・財務情報
    Fujicco Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Fujicco Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Apache Corporation:戦略・SWOT・企業財務分析
    Apache Corporation - Strategy, SWOT and Corporate Finance Report Summary Apache Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆